Direct and Total Effectiveness of the Intranasal, Live-Attenuated, Trivalent Cold-Adapted Influenza Virus Vaccine Against the 2000-2001 Influenza A(H1N1) and B Epidemic in Healthy Children
- 1 January 2004
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 158 (1) , 65-73
- https://doi.org/10.1001/archpedi.158.1.65
Abstract
Research from JAMA Pediatrics — Direct and Total Effectiveness of the Intranasal, Live-Attenuated, Trivalent Cold-Adapted Influenza Virus Vaccine Against the 2000-2001 Influenza A(H1N1) and B Epidemic in Healthy ChildrenKeywords
This publication has 16 references indexed in Scilit:
- Estimating Efficacy of Trivalent, Cold-adapted, Influenza Virus Vaccine (CAIV-T) against Influenza A (H1N1) and B Using Surveillance CulturesAmerican Journal of Epidemiology, 2003
- Safety and effectiveness of the trivalent, cold-adapted influenza vaccine (CAIV-T) in childrenInternational Congress Series, 2001
- Burden of Disease—Implications for Future ResearchJAMA, 2001
- Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic controlVaccine, 2000
- Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccineThe Journal of Pediatrics, 2000
- Influenza and the Rates of Hospitalization for Respiratory Disease among Infants and Young ChildrenNew England Journal of Medicine, 2000
- The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in ChildrenNew England Journal of Medicine, 2000
- Effectiveness of Live, Attenuated Intranasal Influenza Virus Vaccine in Healthy, Working AdultsJAMA, 1999
- Design and Interpretation of Vaccine Field StudiesEpidemiologic Reviews, 1999
- Emerging Infections: Pandemic InfluenzaEpidemiologic Reviews, 1996